Showing results (331-340 of 486) with videos related to
Sort By:
Pageof 49
Oncoimmunology|June 22, 2012
Trial Watch: Monoclonal antibodies in cancer therapyLorenzo Galluzzi, Erika Vacchelli, Wolf Hervé Fridman, et al.Methods in Cell Biology|October 11, 2024
Generation of transmitochondrial cybrids in cancer cellsRuth Soler-Agesta, Cristina Ripollés-Yuba, Joaquín Marco-Brualla, et al.Oncoimmunology|May 7, 2014
Trial Watch: DNA vaccines for cancer therapyJonathan Pol, Norma Bloy, Florine Obrist, et al.Journal of Molecular Medicine (Berlin, Germany)|February 4, 2009
NF-kappaB blockade upregulates Bax, TSP-1, and TSP-2 expression in rat granulation tissueDaniela De Stefano, Giancarlo Nicolaus, Maria Chiara Maiuri, et al.Frontiers in Immunology|June 18, 2015
Corrigendum: "Combinatorial Strategies for the Induction of Immunogenic Cell Death"Lucillia Bezu, Ligia C Gomes-da-Silva, Heleen Dewitte, et al.Cell Cycle (Georgetown, Tex.)|December 22, 2011
Autophagy is required for the activation of NFκBAlfredo Criollo, Fanny Chereau, Shoaib Ahmad Malik, et al.Frontiers in Immunology|May 13, 2015
Combinatorial strategies for the induction of immunogenic cell deathLucillia Bezu, Ligia C Gomes-de-Silva, Heleen Dewitte, et al.Frontiers in Immunology|August 25, 2015
Prognostic and Predictive Value of DAMPs and DAMP-Associated Processes in CancerJitka Fucikova, Irena Moserova, Linda Urbanova, et al.Apoptosis : an International Journal on Programmed Cell Death|January 20, 2009
A chemical inhibitor of Apaf-1 exerts mitochondrioprotective functions and interferes with the intra-S-phase DNA damage checkpointLaura Mondragón, Lorenzo Galluzzi, Shahul Mouhamad, et al.Oncoimmunology|December 25, 2012
Trial watch: Peptide vaccines in cancer therapyErika Vacchelli, Isabelle Martins, Alexander Eggermont, et al.Pageof 49